SYNGENE.NS Profit & Loss
Syngene International Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹3,192.90 Cr. | ₹3,488.60 Cr. | ₹3,642.40 Cr. | ₹3,738.70 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹70.90 Cr. | ₹90.60 Cr. | ₹71.80 Cr. | ₹70.70 Cr. | OtherIncome |
| Total Income | ₹3,263.80 Cr. | ₹3,579.20 Cr. | ₹3,714.20 Cr. | ₹3,809.40 Cr. | Income |
| Cost of Materials Consumed | ₹902.20 Cr. | ₹873.60 Cr. | ₹925.40 Cr. | ₹911.20 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-42.00 Cr. | ₹56.60 Cr. | ₹17.10 Cr. | ₹7.40 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹841.70 Cr. | ₹888.70 Cr. | ₹983.90 Cr. | ₹1,104.90 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹45.20 Cr. | ₹47.20 Cr. | ₹53.10 Cr. | ₹48.80 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹366.50 Cr. | ₹425.90 Cr. | ₹432.60 Cr. | ₹452.90 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹556.60 Cr. | ₹655.30 Cr. | ₹674.20 Cr. | ₹796.70 Cr. | OtherExpenses |
| Total Expenses | ₹2,670.20 Cr. | ₹2,947.30 Cr. | ₹3,086.30 Cr. | ₹3,321.90 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹593.60 Cr. | ₹631.90 Cr. | ₹627.90 Cr. | ₹487.50 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹-11.10 Cr. | ₹32.00 Cr. | ₹-76.60 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹593.60 Cr. | ₹620.80 Cr. | ₹659.90 Cr. | ₹410.90 Cr. | ProfitBeforeTax |
| Tax Expense | ₹129.20 Cr. | ₹110.80 Cr. | ₹163.70 Cr. | ₹94.20 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹464.40 Cr. | ₹510.00 Cr. | ₹496.20 Cr. | ₹316.70 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹0.00 Cr. | N/A | ₹0.00 Cr. | ₹0.00 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹11.59 | ₹12.71 | ₹12.35 | ₹7.87 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹11.51 | ₹12.69 | ₹12.34 | ₹7.87 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from SYNGENE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).